Due to the high incidence of breast cancer worldwide and its relatively high mortality and morbidity, it is important to implement appropriate screening tests which enable rapid and efficient mutation screening in the BRCA1 and BRCA2 genes. This evidence concerns the gene BRCA1 and breast cancer.